Zydus gains final USFDA approval for Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg Read more
Biocon Biologics report explores pathways to increase biosimilar adoption in low- and middle-income countries Read more
Aurigene Oncology announces phase 1 results for India’s first CAR-T cell therapy in multiple Myeloma Read more